Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The roles of histone deacetylases in kidney development and disease

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Histone deacetylases (HDACs) are important epigenetic regulators that mediate deacetylation of both histone and non-histone proteins. HDACs, especially class I HDACs, are highly expressed in developing kidney and subject to developmental control. HDACs play an important role in kidney formation, especial nephron progenitor maintenance and differentiation. Several lines of evidence support the critical role of HDACs in the development and progression of various kidney diseases. HDAC inhibitors (HDACis) are very effective in the prevention and treatment of kidney diseases (including kidney cancer). A better understanting of the molecular mechanisms underlying the role(s) of HDACs in the pathogenesis and progression of renal disease are likely to be of great help in developing more effective and less toxic selective HDAC inhibitors and combinatorial therapeutics.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: not found

          Erasers of histone acetylation: the histone deacetylase enzymes.

          Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl functional groups from the lysine residues of both histone and nonhistone proteins. In humans, there are 18 HDAC enzymes that use either zinc- or NAD(+)-dependent mechanisms to deacetylate acetyl lysine substrates. Although removal of histone acetyl epigenetic modification by HDACs regulates chromatin structure and transcription, deacetylation of nonhistones controls diverse cellular processes. HDAC inhibitors are already known potential anticancer agents and show promise for the treatment of many diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The many roles of histone deacetylases in development and physiology: implications for disease and therapy.

            Histone deacetylases (HDACs) are part of a vast family of enzymes that have crucial roles in numerous biological processes, largely through their repressive influence on transcription. The expression of many HDAC isoforms in eukaryotic cells raises questions about their possible specificity or redundancy, and whether they control global or specific programmes of gene expression. Recent analyses of HDAC knockout mice have revealed highly specific functions of individual HDACs in development and disease. Mutant mice lacking individual HDACs are a powerful tool for defining the functions of HDACs in vivo and the molecular targets of HDAC inhibitors in disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development.

              Nephrons, the basic functional units of the kidney, are generated repetitively during kidney organogenesis from a mesenchymal progenitor population. Which cells within this pool give rise to nephrons and how multiple nephron lineages form during this protracted developmental process are unclear. We demonstrate that the Six2-expressing cap mesenchyme represents a multipotent nephron progenitor population. Six2-expressing cells give rise to all cell types of the main body of the nephron during all stages of nephrogenesis. Pulse labeling of Six2-expressing nephron progenitors at the onset of kidney development suggests that the Six2-expressing population is maintained by self-renewal. Clonal analysis indicates that at least some Six2-expressing cells are multipotent, contributing to multiple domains of the nephron. Furthermore, Six2 functions cell autonomously to maintain a progenitor cell status, as cap mesenchyme cells lacking Six2 activity contribute to ectopic nephron tubules, a mechanism dependent on a Wnt9b inductive signal. Taken together, our observations suggest that Six2 activity cell-autonomously regulates a multipotent nephron progenitor population.
                Bookmark

                Author and article information

                Contributors
                hliu8@tulane.edu
                Journal
                Clin Exp Nephrol
                Clin Exp Nephrol
                Clinical and Experimental Nephrology
                Springer Singapore (Singapore )
                1342-1751
                1437-7799
                4 January 2021
                4 January 2021
                2021
                : 25
                : 3
                : 215-223
                Affiliations
                GRID grid.265219.b, ISNI 0000 0001 2217 8588, Department of Pediatrics and The Tulane Hypertension and Renal Center of Excellence, , Tulane University School of Medicine, ; SL-37, 1430 Tulane Avenue, New Orleans, LA 70112 USA
                Author information
                http://orcid.org/0000-0002-3411-4597
                Article
                1995
                10.1007/s10157-020-01995-5
                7925501
                33398599
                907ba355-d735-40a3-a590-dc90465b0882
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 17 November 2019
                : 10 November 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000968, American Heart Association;
                Award ID: 17SDG33660072
                Award Recipient :
                Categories
                Review Article
                Custom metadata
                © Japanese Society of Nephrology 2021

                Nephrology
                histone deacetylases,histone deacetylase inhibitors,kidney disease,kidney cancer
                Nephrology
                histone deacetylases, histone deacetylase inhibitors, kidney disease, kidney cancer

                Comments

                Comment on this article